Shree Pacetronix Ltd.
Snapshot View

View in App

Prices View details >>

99.00 +3.90 ▲4.1%

07 February 2023, 04:01:00 PM
Volume: 444

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.pacetronix.com
Market Cap 35.63 Cr.
Enterprise Value(EV) 37.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.96 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 33.49 Trailing Twelve Months Ending 2022-09
Industry PE 54.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 19.73 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.02 Calculated using Price: 99.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.36 Cr. 3,599,400 Shares
FaceValue 10
Company Profile
Shree Pacetronix was incorporated on January 11, 1988 as a Pvt. Ltd. company. In 1993 the company was converted to a Public Limited Company. The company is listed on Bombay Stock Exchange and regional exchanges and has strength of about 7000 shareholders today.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.10%
1 Week
+3.83%
1 Month
+12.88%
3 Month
-36.17%
6 Month
+244.95%
1 Year
+303.26%
2 Year
+900%
5 Year
+685.71%
10 Year
+330.43%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.29 -1.11 -1.61 -6.34 2.61 2.68 4.34 0.95 12.96
Return on Capital Employed (%) 10.61 3.82 4.18 -0.64 6.51 6.63 8.05 5.46 14.81
Return on Assets (%) 2.52 -0.67 -0.97 -3.79 1.48 1.43 2.23 0.49 6.90

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5 5 5 5 5 5 6 6 6 7
Non Curr. Liab. 0 0 0 0 1 1 0 0 0 0
Curr. Liab. 3 3 3 3 3 4 5 5 5 7
Minority Int.
Equity & Liab. 9 9 9 9 9 10 11 11 12 14
Non Curr. Assets 4 3 3 3 3 4 4 5 4 5
Curr. Assets 5 6 6 6 6 7 6 6 7 9
Misc. Exp. not W/O
Total Assets 9 9 9 9 9 10 11 11 12 14

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 8 7 7 7 7 7 9 8 9 12
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 7 7 7 7 7 9 8 9 12
Total Expenditure -7 -6 -6 -6 -6 -7 -8 -7 -7 -10
PBIDT 1 1 1 1 1 1 1 1 2 2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 0 0 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 1 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0 0 0 0 0 0 1 1
Adjusted EPS 1 0 0 -1 0 0 1 0 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 1 0 1 0 1 0 2 1 2
Cash Fr. Inv. 0 0 0 0 -1 -1 -1 -1 -1 0
Cash Fr. Finan. -1 -1 0 -1 0 -1 0 -1 0 0
Net Change 0 0 0 0 0 0 0 0 0 1
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25
Public 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 04 Feb 2023
Board Meeting Intimation for Intimation Of B.M (09Th/2022-2023) Of The Company Under Reg.29(1) And (2) Of SEBI (LODR) Reg. 2015 To Inter-Alia Consider And Approve The Standalone And Consolidated Unaudited Financial Results For The Quarter/Nine Months Ended 31.12.2022.
SHREE PACETRONIX LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve With reference to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 we wish to inform you that 09th/2022-2023 Meeting of the Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 at 03.00 P.M. at the registered office of the Company i.e. "Plot No 15 Sector-II Industrial Area Pithampur District Dhar (M.P.) 454775 to inter alia transact the following businesses along with other administrative and operational businesses:1.To Consider & Approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter/nine months period ended 31st December 2022.2.To take on record the Standalone and Consolidated Auditors Limited Review Report along with modified/unmodified opinion on the Financial Results for the Quarter/nine months ended 31st December 2022.
Thu, 12 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/Maam In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 SEBI Circulars and based on the intimation received from Registrar and Transfer Agents (RTA) M/s. Ankit Consultancy Private Limited this is to inform you that the below shareholder has reported the misplaced/lost of its share certificate and has requested us to issue duplicate share certificate in lieu of original Details enclosed in PDF for Mr. Tazeen Elahi (Folio No.Z004640)
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December 2022 based on the certificate (enclosed herewith) received from our Registrar and Share Transfer Agent M/s Ankit Consultancy Pvt. Ltd. we hereby confirm that within 15 days of receipt of the securities received for dematerialization that:a) The securities comprised in the said Certificate(s) have been listed on the Stock Exchange; andb) The said Certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been submitted in Register of Members as the registered owner.

Technical Scans View Details >>

Tue, 07 Feb 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 6 Months High Increase in 6 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,256.90 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,135.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,898.92 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Shree Pacetronix Ltd.

What is Shree Pacetronix share price?
Can I buy Shree Pacetronix shares now?
What is the Market Cap of Shree Pacetronix?
What are the key metrics to analyse Shree Pacetronix?
What is the 52 Week High and Low of Shree Pacetronix?
What is the trend of Shree Pacetronix share price?